相关实验视频
Updated: May 20, 2025

10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
3.0K
针对性控制的镇静与普罗波福尔输液用于PEG-J安置在晚期帕金森病:关于安全性和可行性的前性观察性研究
Janos Szederjesi1, Irina Săplăcan1, Alexandra Lazăr1
1Department of Intensive Care, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu-Mureș, 540139 Târgu Mureș, Romania.
Life (Basel, Switzerland)
|March 27, 2025
概括
向受控输注 (TCI) 布罗波镇静剂在晚期帕金森病 (PD) 患者的皮肤内镜胃口管切除术 (PEG-J) 放置中有效. 这种镇静方法在罗马尼亚的一项研究中证明了高的程序成功率和30天死亡率.
科学领域:
- 神经学 神经学
- 胃肠病学 胃肠病学
- 麻醉学 麻醉学
背景情况:
- 在晚期帕金森病 (PD) 中,皮肤透视内镜胃口静止术 (PEG-J) 的镇静是复杂的.
- 病症治疗,麻醉剂和疾病症状的相互作用是独一无二的.
研究的目的:
- 为了评估目标控制输液 (TCI) 醇在晚期PD患者的PEG-J安置中的有效性和安全性.
- 评估程序的成功和不良结果.
主要方法:
- 对169名晚期PD患者的前性研究 (Hoehn和Yahr阶段4-5).
- 用二和阿片类药物进行TCI普罗波镇静的PEG-J安置;没有使用肌肉松剂.
- 程序成功和不良事件的30天评估.
主要成果:
- 通过TCI propofol协议实现的高程序成功率.
- 在手术后的30天内没有报告死亡.
结论:
- 在TCI的Propofol协议是可行的和临床上适用于PEG-J在晚期PD (阶段4-5).
- 由于样本大小的限制,需要进一步研究来确认长期的安全性.
相关概念视频
Parkinson's Disease: Treatment
166
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
166
Parenteral Anesthetics: Overview
88
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
88
Parkinson's Disease: Overview
399
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
399
Depolarizing Blockers: Pharmocokinetics
298
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
298
Drug Delivery: Parenteral Route
353
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
353

